Graft-versus-Tumor Effect According to Type of Graft-versus-Host Disease Defined by National Institutes of Health Consensus Criteria and Associated Outcomes-Reference-Cited by-同舟云学术

Graft-versus-Tumor Effect According to Type of Graft-versus-Host Disease Defined by National Institutes of Health Consensus Criteria and Associated Outcomes

Published:2012-07 Issue:7 Volume:18 Page:1136-1143
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Cho Byung-Sik,Lee Sung-Eun,Song Hae-Hiang,Lee Ju-Hyoung,Yahng Seung-Ah,Eom Ki-Seong,Kim Yoo-Jin,Kim Hee-Je,Lee Seok,Min Chang-Ki,Cho Seok-Goo,Kim Dong-Wook,Lee Jong-Wook,Min Woo-Sung,Park Chong-Won

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference40 articles.

1. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, I: Diagnosis and Staging Working Group report;Filipovich;Biol Blood Marrow Transplant,2005

2. Chronic graft-versus-host disease;Lee;Biol Blood Marrow Transplant,2003

3. Graft-versus-host disease;Ferrara;Lancet,2009

4. 1994 Consensus Conference on acute GVHD grading;Przepiorka;Bone Marrow Transplant,1995

5. Feasibility of NIH consensus criteria for chronic graft-versus-host disease;Cho;Leukemia,2009

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Propensity Score Matching Analysis Comparing the Efficacy and Steroid Tapering Benefit of Extracorporeal Photopheresis to Best Available Therapy in Third-Line or Beyond Treatment for Chronic GvHD;Transplantation and Cellular Therapy;2023-12

2. Circulating T cell profiles associate with enterotype signatures underlying hematological malignancy relapses;Cell Host & Microbe;2023-08

3. Propensity score matching analysis comparing the efficacy of Ruxolitinib to historical controls in second-line or beyond treatment for chronic GvHD after steroid failure;Bone Marrow Transplantation;2023-06-26

4. Population-based real-world registry study to evaluate clinical outcomes of chronic graft-versus-host disease;PLOS ONE;2023-03-09

5. Low‐dose thymoglobulin for prevention of chronic graft‐versus‐host disease in transplantation from an HLA ‐matched sibling donor;American Journal of Hematology;2021-08-27